The platform is described in a peer-reviewed publication in JACC: Basic to Translational Science under the title: “Next-Generation Percutaneous Catheter–Based Closed-Loop Perfusion Concept Enables ...
Sequential embolisation and renal cryoablation shows high efficacy and low severe adverse events in patients with renal ...
Background Although chest X-rays (CXRs) are widely used, diagnosing mitral stenosis (MS) based solely on CXR findings remains ...
A new meta-analysis suggests that peritoneal dialysis catheter placement using either laparoscopic or percutaneous techniques ...
Edwards Lifesciences has received the US Food and Drug Administration (FDA) approval for its SAPIEN M3 mitral valve ...
Women with severe coronary heart disease causing narrowing or blockages in the arteries may derive greater long-term benefits ...
Aortic stenosis is a narrowing of the aortic valve, which connects the heart to the rest of the body. It affects millions of ...
Currently, no FDA-approved drug therapies exist for pediatric patients with abdominal pain related to functional dyspepsia, a significant unmet medical need. In the absence of approved options, ...
Pulse Biosciences announced today that the FDA granted investigational device exemption (IDE) for a pulsed field ablation (PFA) study.
December 15, 2025Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for ...
SAN FRANCISCO, CA—A novel percutaneous ventricular assist device (pVAD) appears to offer comparable safety to an intra-aortic balloon pump (IABP) when offering hemodynamic stabilization in elective, ...
Dr. Mehran is a co-Principal Investigator of the breakthrough "SELUTION4ISR Trial," with results presented at Transcatheter Cardiovascular Therapeutics 2025. A new drug-eluting balloon can perform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback